Search the Newsreel

Bronstein, Gewirtz & Grossman LLC Urges Cogent Communications Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Cogent Communications Holdings, Inc. (CCOI) alleging that the company and its officers made misleading statements regarding its business, operations, and financial condition. The lawsuit, filed by Bronstein, Gewirtz & Grossman, LLC, claims that Cogent overstated customer …

Kaplan Fox Advises Cogent Communications Holdings, Inc. (NASDAQ: CCOI) Investors to Act Before the Lead Plaintiff Deadline on September 21, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Cogent Communications Holdings, Inc. (NASDAQ: CCOI) on behalf of investors who purchased securities between February 29, 2024, and May 1, 2026. The lawsuit alleges that Cogent misrepresented the strength of demand for …

CCOI Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in COGENT COMMUNICATIONS HOLDINGS, INC. Securities Lawsuit - Contact Levi & Korsinsky

Levi & Korsinsky, LLP has issued a shareholder alert for investors in Cogent Communications Holdings, Inc. (NASDAQ: CCOI) regarding a pending securities class action lawsuit. The lawsuit alleges that Cogent made misleading statements about the sustainability of its dividend policy and risks associated with …

Emergent BioSolutions (EBS) EVP Stephanie Duatschek details stock and option holdings

Emergent BioSolutions' Executive Vice President and Chief Growth Officer, Stephanie Duatschek, has reported her initial equity holdings, which include 197,416 shares of common stock and various employee stock options. Her holdings comprise 55,639 direct common shares and 141,777 unvested Restricted Stock Units (RSUs), with …

Versigent's (NYSE:VGNT) Earnings May Just Be The Starting Point

Versigent's recent strong earnings are potentially understated due to unusual items that reduced profit by US$181 million. These one-off expenses suggest that the company's future profitability could be higher if these items do not recur. Investors should consider this factor when evaluating Versigent's earnings …

Deutsche Bank Adjusts Lithium Argentina PT to $8.75 From $10, Maintains Buy Rating

Deutsche Bank has revised its price target for Lithium Argentina (LAR) down to $8.75 from $10, while reiterating a "Buy" rating on the stock. This adjustment comes amidst recent company news including its Q2 2026 earnings report, where Lithium Argentina swung to a profit. …

Cogent Biosciences, Inc. (NASDAQ:COGT) Given Average Recommendation of "Moderate Buy" by Brokerages

Cogent Biosciences (NASDAQ:COGT) has received an average "Moderate Buy" recommendation from thirteen brokerages, with an average 12-month price target of $45.90. The company recently reported quarterly EPS of -$0.52, exceeding the consensus estimate. Institutional investors have also increased their holdings in the company.

CCC Intelligent Solutions Holdings Inc. Common Stock $CCC Stake Trimmed by Wasatch Advisors LP

Wasatch Advisors LP significantly reduced its stake in CCC Intelligent Solutions Holdings Inc. Common Stock (NASDAQ:CCC) by 44.9% in the second quarter, selling over 12.6 million shares. Despite this reduction, other hedge funds increased their positions in CCC. Analysts have varied ratings on the …

Should I Buy BBVA (Banco Bilbao Vizcaya Argentaria, S.A.) | AI Analysis, Technical & News Insights

BBVA posts strong Q2 2026 with 23% loan growth but valuation looks stretched at 2.45x P/BV.

Banco Bilbao Vizcaya Argentaria (BBVA) reported strong Q2 2026 results, driven by a 23% year-over-year rise in net interest income, particularly from Spain and Mexico, achieving a 21% return on equity and €3 billion net profit. However, rising operating expenses tempered operating leverage. Despite …

Sanhua Intelligent Controls Sets Board Meeting to Approve 2026 Interim Results

Cogent Communications Holdings, Inc. Stock 12‑Month Price Target Raised to $20.75, Implies 92% Upside

The average 12-month price target for Cogent Communications Holdings, Inc. (CCOI) stock has been raised to $20.75 from $20.41 by 10 analysts, suggesting a potential upside of approximately 92% based on the recent closing price. The consensus analyst rating remains a "Buy" across 12 …

BBVA: Good Operating Performance, But The Valuation Is Too High (NYSE:BBVA)

Banco Bilbao Vizcaya Argentaria, S.A. delivered strong Q2 2026 results with robust loan growth and a 23% YoY increase in net interest income, achieving a 21% ROE and €3 billion net profit. Despite this operational strength, the article suggests that the current 2.45x P/BV …

Stocks in play: Lithium Argentina AG

Lithium Argentina AG announced its second-quarter 2026 financial results, reporting a net income of $27 million and adjusted EBITDA of $110 million. Despite higher realized prices, net income decreased compared to the previous quarter due to lower sales volumes. Following the announcement, shares of …

Earnings Flash (LAR) Lithium Argentina AG Reports Q2 Net Income $1.3M

Lithium Argentina AG announced a net income of $1.3 million for the second quarter of 2026. The company, operating in the mining industry and focused on lithium production in Argentina, also reported its earnings results for the six months ended June 30, 2026. This …

Lithium Argentina advances 10,000-tonne Stage 2 expansion

Lithium Argentina (LAR) reported strong Q2 2026 results from its Cauchari-Olaroz project, including $141 million in free cash flow and a significant reduction in net debt. The company is advancing its Stage 2 expansion, which aims to increase lithium carbonate equivalent (LCE) production capacity …

Lithium Argentina AG Earnings Call Highlights Growth Momentum

Lithium Argentina AG Q2 2026 Earnings Call Summary

Intelligent Living Application Group Inc (ILAG) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Intelligent Living Application Group Inc (ILAG), detailing future EPS and revenue growth estimates. It includes a snapshot of the company's current stock performance, market capitalization, and a list of peer companies for comparison. The content was updated …

Lithium Argentina Reports Second Quarter 2026 Results

Lithium Argentina AG announced its second quarter 2026 results, highlighting strong performance from its Cauchari-Olaroz operation, which generated over $141 million in free cash flow and reduced net debt by $114 million. The company produced 9,280 tonnes of lithium carbonate, maintaining an average of …

Banco BBVA Argentina SA (BBAR) Shares Fall 4.7% -- What GF Score of 63 Tells Investors

Lithium Argentina AG Stock 12‑Month Price Target Cut to $12.19, Implies 72% Upside

Analysts have lowered the average 12-month price target for Lithium Argentina AG stock from $12.55 to $12.19, with individual forecasts ranging from $8.5 to $21 per share. Despite the cut, this updated target still suggests a potential upside of approximately 72% from the August …

Kaplan Fox Encourages Cogent Communications Holdings, Inc. (NASDAQ: CCOI) Investors Seeking Recovery to Contact the Firm Before September 21, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Cogent Communications Holdings, Inc. (NASDAQ: CCOI) on behalf of investors who purchased securities between February 29, 2024, and May 1, 2026. The lawsuit alleges that Cogent misrepresented the demand for optical wavelengths …

INTELLIGENT PROTECTION MANAGEMENT ($IPM) Releases Q2 2026 Earnings

A Look at Telecom Argentina SA (TEO) After 5.6% Decline -- GF Va

Intelligent Protection Management earnings missed by $0.12, revenue fell short of estimates

Form 8K Intelligent Bio Solutions Inc For: 11 August By Investing.com

This article announces that Intelligent Bio Solutions Inc. filed a Form 8K on August 11. The filing is a standard regulatory disclosure for significant events that shareholders should know about. The brief piece indicates that Investing.com is the source of this financial news.

Intelligent Bio Solutions completes multi-site study, targets FDA 510(k) submission in H2 2026

Intelligent Bio Solutions (INBS) has completed its multi-site Method Comparison Study for its Intelligent Fingerprinting Drug Screening System. All clinical data collection for its FDA 510(k) program is now complete. The company is currently analyzing data and preparing the submission package, aiming for FDA …

Is Intelligent Protection Management Corp (IPM) Overvalued After

Intelligent Protection Management Q2 2026 Earnings Call Transcript

Versigent Jumps 5.0% After Evercore ISI Group Maintains Outperform

Versigent PLC's stock surged 5.0% after four major Wall Street firms either upgraded their ratings or raised price targets, pushing the average new target to $58 per share. Evercore ISI Group maintained its Outperform rating and increased its price target to $65, leading the …

Intelligent Protection (Nasdaq: IPM) grows Q2 2026 revenue but widens loss

Intelligent Protection Management Corp. Reports Second Quarter 2026 Financial Results

Trade Desk, Papa John's, Emergent BioSolutions Hit 52-Week Lows as Weak Results Trigger Analyst Downgrades

Trade Desk, Papa John's, and Emergent BioSolutions all hit 52-week lows following disappointing quarterly results and subsequent analyst downgrades. Trade Desk faced a significant downgrade after missing revenue estimates and providing weak guidance, while Papa John's experienced a revenue decline despite an earnings beat. …

Telecom Argentina Stet - France Telecom (NYSE:TEO) Shares Down 5.6% - Here's What Happened

Telecom Argentina Stet - France Telecom (NYSE:TEO) shares dropped 5.6% during Tuesday trading, with significantly reduced trading volume. Despite mixed analyst ratings, including upgrades to "overweight" by Morgan Stanley and JPMorgan, the stock has a consensus "Hold" rating with a $15.55 price target. Insider …

EBS SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Emergent BioSolutions

SueWallSt, powered by Levi & Korsinsky LLP, has announced an investigation into potential securities law violations by Emergent BioSolutions (NYSE: EBS). This follows Emergent BioSolutions lowering its FY2026 adjusted EBITDA guidance and recording a significant non-cash NARCAN impairment due to increased competition and pricing …